QTLs in Region (mRatBN7.2)
RGD ID | Symbol | Name | LOD | P Value | Trait | Sub Trait | Chr | Start | Stop | Species | 12801411 | Schws8 | Schwannoma susceptibility QTL 8 | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 6 | 94968928 | 139968928 | Rat | 1331799 | Bp211 | Blood pressure QTL 211 | 3.66407 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 6 | 72202632 | 130919985 | Rat | 634330 | Pia16 | Pristane induced arthritis QTL 16 | 3.9 | joint integrity trait (VT:0010548) | arthritic paw count (CMO:0001460) | 6 | 45790088 | 104200226 | Rat | 1331789 | Rf37 | Renal function QTL 37 | 3.224 | kidney blood vessel physiology trait (VT:0100012) | absolute change in renal vascular resistance (CMO:0001900) | 6 | 72202632 | 115200186 | Rat | 1331725 | Bp212 | Blood pressure QTL 212 | 3.52475 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 6 | 93701310 | 128713626 | Rat | 1331722 | Thshl1 | Thyroid stimulating hormone level QTL 1 | 11.7 | 0.0001 | blood thyroid-stimulating hormone amount (VT:0005119) | serum thyroid stimulating hormone level (CMO:0001248) | 6 | 89762877 | 106752806 | Rat | 4145119 | Mcs25 | Mammary carcinoma susceptibility QTL 25 | 0.0001 | mammary gland integrity trait (VT:0010552) | ratio of deaths to total study population during a period of time (CMO:0001023) | 6 | 10894415 | 110548006 | Rat | 70176 | Mcsm1 | Mammary carcinoma susceptibility modifier QTL 1 | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 6 | 58632962 | 103632962 | Rat | 1581563 | Uae33 | Urinary albumin excretion QTL 33 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 72227641 | 130729205 | Rat | 10054138 | Gmadr3 | Adrenal mass QTL 3 | 3.68 | 0.00045 | adrenal gland mass (VT:0010420) | both adrenal glands wet weight (CMO:0000164) | 6 | 85140138 | 130140138 | Rat | 1558641 | Cm47 | Cardiac mass QTL 47 | 2.9 | 0.001 | heart mass (VT:0007028) | heart wet weight (CMO:0000069) | 6 | 57730540 | 104085867 | Rat | 61414 | Pia3 | Pristane induced arthritis QTL 3 | 4.5 | joint integrity trait (VT:0010548) | post-insult time to onset of experimental arthritis (CMO:0001450) | 6 | 94968928 | 137848904 | Rat | 724524 | Uae2 | Urinary albumin excretion QTL 2 | 2.7 | 0.0005 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 73463459 | 109394713 | Rat | 737827 | Hcar11 | Hepatocarcinoma resistance QTL 11 | 4.4 | liver integrity trait (VT:0010547) | liver tumorous lesion number (CMO:0001068) | 6 | 82523650 | 110548006 | Rat | 1641904 | Alcrsp4 | Alcohol response QTL 4 | response to alcohol trait (VT:0010489) | duration of loss of righting reflex (CMO:0002289) | 6 | 67262953 | 112262953 | Rat | 724513 | Uae14 | Urinary albumin excretion QTL 14 | 6.5 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 85311061 | 133478515 | Rat | 2303624 | Vencon5 | Ventilatory control QTL 5 | 4.45 | respiration trait (VT:0001943) | minute ventilation (CMO:0000132) | 6 | 88047916 | 133047916 | Rat | 1576309 | Emca7 | Estrogen-induced mammary cancer QTL 7 | 4 | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 6 | 15107216 | 107351382 | Rat | 731173 | Uae22 | Urinary albumin excretion QTL 22 | 10.1 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 65531555 | 140994061 | Rat | 2293837 | Kiddil1 | Kidney dilation QTL 1 | 3.7 | kidney pelvis morphology trait (VT:0004194) | hydronephrosis severity score (CMO:0001208) | 6 | 81132889 | 104393926 | Rat | 2293842 | Kiddil3 | Kidney dilation QTL 3 | 4.3 | kidney pelvis morphology trait (VT:0004194) | hydronephrosis severity score (CMO:0001208) | 6 | 81132889 | 104393926 | Rat | 10054123 | Srcrt6 | Stress Responsive Cort QTL 6 | 2.5 | 0.0043 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 6 | 85140138 | 130140138 | Rat | 724536 | Uae7 | Urinary albumin excretion QTL 7 | 3.5 | urine albumin amount (VT:0002871) | urine albumin level (CMO:0000130) | 6 | 72202632 | 130729475 | Rat | 70196 | BpQTLcluster7 | Blood pressure QTL cluster 7 | 6.82 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 6 | 72202632 | 117202632 | Rat | 1581550 | Pur8 | Proteinuria QTL 8 | urine total protein amount (VT:0000032) | urine total protein excretion rate (CMO:0000756) | 6 | 72227641 | 130729205 | Rat | 1576302 | Schws4 | Schwannoma susceptibility QTL 4 | 0.0078 | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 6 | 83190345 | 106747639 | Rat | 1300075 | Glom7 | Glomerulus QTL 7 | 5.6 | 0.0000002 | kidney glomerulus morphology trait (VT:0005325) | count of superficial glomeruli not directly contacting the kidney surface (CMO:0001002) | 6 | 71201409 | 116201409 | Rat | 738034 | Anxrr5 | Anxiety related response QTL 5 | 5.9 | exploratory behavior trait (VT:0010471) | percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) | 6 | 84130881 | 129130881 | Rat | 2290393 | Uae37 | Urinary albumin excretion QTL 37 | 0.0001 | urine albumin amount (VT:0002871) | urine albumin excretion rate (CMO:0000757) | 6 | 65531555 | 140994061 | Rat | 12801471 | Schws9 | Schwannoma susceptibility QTL 9 | nervous system integrity trait (VT:0010566) | percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) | 6 | 61747639 | 106747639 | Rat | 6893332 | Cm74 | Cardiac mass QTL 74 | 0.4 | 0.64 | heart mass (VT:0007028) | heart weight to body weight ratio (CMO:0000074) | 6 | 57730540 | 104085867 | Rat | 1300076 | Glom8 | Glomerulus QTL 8 | 7 | 9e-09 | kidney glomerulus morphology trait (VT:0005325) | count of superficial glomeruli directly contacting the kidney surface (CMO:0001001) | 6 | 86894788 | 131894788 | Rat | |
Markers in Region
D6Mit1 |
|
|||||||||||||||||||||||||||||||||||||||||||||
AU049679 |
|
Expression
RNA-SEQ Expression
alimentary part of gastrointestinal system
|
appendage
|
circulatory system
|
ectoderm
|
endocrine system
|
endoderm
|
exocrine system
|
hemolymphoid system
|
hepatobiliary system
|
integumental system
|
mesenchyme
|
mesoderm
|
nervous system
|
renal system
|
reproductive system
|
respiratory system
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7 | 5 | 36 | 108 | 84 | 86 | 56 | 24 | 56 | 6 | 180 | 78 | 91 | 35 | 58 | 30 |
Sequence
Nucleotide Sequences
Ensembl Acc Id: | ENSRNOT00000058675 ⟹ ENSRNOP00000055470 | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
Ensembl Acc Id: | ENSRNOT00000088808 ⟹ ENSRNOP00000073922 | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
RefSeq Acc Id: | NM_001025658 ⟹ NP_001020829 | ||||||||||||||||||||||||||||
RefSeq Status: | VALIDATED | ||||||||||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||||||||||
Position: |
|
||||||||||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_006240226 ⟹ XP_006240288 | ||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||
Position: |
|
||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_006240227 ⟹ XP_006240289 | ||||||||||||||||||||
Type: | CODING | ||||||||||||||||||||
Position: |
|
||||||||||||||||||||
Sequence: |
RefSeq Acc Id: | XM_039112011 ⟹ XP_038967939 | ||||||||||||
Type: | CODING | ||||||||||||
Position: |
|
RefSeq Acc Id: | XM_063261717 ⟹ XP_063117787 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261718 ⟹ XP_063117788 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261719 ⟹ XP_063117789 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261720 ⟹ XP_063117790 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261721 ⟹ XP_063117791 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261722 ⟹ XP_063117792 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261723 ⟹ XP_063117793 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261724 ⟹ XP_063117794 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261725 ⟹ XP_063117795 | ||||||||
Type: | CODING | ||||||||
Position: |
|
RefSeq Acc Id: | XM_063261726 ⟹ XP_063117796 | ||||||||
Type: | CODING | ||||||||
Position: |
|
Protein Sequences
RefSeq Acc Id: | NP_001020829 ⟸ NM_001025658 |
- UniProtKB: | Q4V8E7 (UniProtKB/TrEMBL), A0A0G2K6S3 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_006240288 ⟸ XM_006240226 |
- Peptide Label: | isoform X3 |
- UniProtKB: | A0A0G2K6S3 (UniProtKB/TrEMBL) |
- Sequence: |
RefSeq Acc Id: | XP_006240289 ⟸ XM_006240227 |
- Peptide Label: | isoform X3 |
- UniProtKB: | A0A0G2K6S3 (UniProtKB/TrEMBL) |
- Sequence: |
Ensembl Acc Id: | ENSRNOP00000055470 ⟸ ENSRNOT00000058675 |
Ensembl Acc Id: | ENSRNOP00000073922 ⟸ ENSRNOT00000088808 |
RefSeq Acc Id: | XP_038967939 ⟸ XM_039112011 |
- Peptide Label: | isoform X4 |
- UniProtKB: | A0A0G2K6S3 (UniProtKB/TrEMBL) |
RefSeq Acc Id: | XP_063117792 ⟸ XM_063261722 |
- Peptide Label: | isoform X5 |
RefSeq Acc Id: | XP_063117793 ⟸ XM_063261723 |
- Peptide Label: | isoform X6 |
RefSeq Acc Id: | XP_063117794 ⟸ XM_063261724 |
- Peptide Label: | isoform X6 |
RefSeq Acc Id: | XP_063117787 ⟸ XM_063261717 |
- Peptide Label: | isoform X1 |
RefSeq Acc Id: | XP_063117788 ⟸ XM_063261718 |
- Peptide Label: | isoform X1 |
RefSeq Acc Id: | XP_063117789 ⟸ XM_063261719 |
- Peptide Label: | isoform X2 |
RefSeq Acc Id: | XP_063117790 ⟸ XM_063261720 |
- Peptide Label: | isoform X2 |
RefSeq Acc Id: | XP_063117796 ⟸ XM_063261726 |
- Peptide Label: | isoform X7 |
RefSeq Acc Id: | XP_063117795 ⟸ XM_063261725 |
- Peptide Label: | isoform X7 |
RefSeq Acc Id: | XP_063117791 ⟸ XM_063261721 |
- Peptide Label: | isoform X4 |